<a href="https://www.fiercebiotech.com/research/aacr-former-genentech-leader-engineers-startup-vision-smart-cancer-drugs" hreflang="en">AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs</a>
fiercebiotech.com·Apr 19, 2026
Daniel Chen, M.D., Ph.D., has transitioned from sketching designs for antibody-drug conjugates in his backyard to launching a biotech startup that develops innovative "smart" cancer drugs.
For a professional interested in healthtech and biotech, the key learning here is the rapid transition from concept to startup in the biotech space, highlighting the potential for innovative cancer treatments like "smart" drugs. This underscores the importance of fostering creative ideas and collaborations early, as they can quickly evolve into viable startups with a focus on cutting-edge treatments in oncology.